Reduced nitric oxide synthase and cyclo-oxygenase activity in the uterus of non-obese diabetic mice

Reproduction

Volumn 132, Issue 6, 2006, Pages 931-938

  Roca, Valeria ^a   Larocca, Luciana ^a   Calafat, Mario ^a   Aisemberg, Julieta ^b   Meiss, Roberto ^c   Franchi, Ana M ^b   Leirós, Claudia Pérez ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Centre de Estudios Farmacologicos y Botanicos   (Argentina)

^c ACADEMIA NACIONAL DE MEDICINA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; NEUROPEPTIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROGESTERONE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; EXOCRINE GLAND; FEMALE; IMPAIRED GLUCOSE TOLERANCE; MOUSE; NIDATION; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROESTRUS; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SJOEGREN SYNDROME; SMOOTH MUSCLE RELAXATION; TH1 CELL; TH2 CELL; UTERUS; VASODILATATION;

ANIMALS; CYCLOOXYGENASE INHIBITORS; DIABETES MELLITUS, TYPE 1; DINOPROSTONE; ENZYME ACTIVATION; FEMALE; IMMUNOHISTOCHEMISTRY; INDOMETHACIN; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MODELS, ANIMAL; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; PREGNANCY; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SJOGREN'S SYNDROME; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA; UTERUS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 33845965335     PISSN: 14701626     EISSN: None     Source Type: Journal    
DOI: 10.1530/rep.1.01050     Document Type: Article

References (52)

1. Andronowska A, Wasowska B, Calka J & Doboszynska T 2005 Localization and correlation between NADPH-diaphorase and nitric oxide synthase isoforms in the porcine uterus during the estrous cycle. Cell and Tissue Research 321 243-250.
2. Bornstein SR, Rutkowski H & Vrezas I 2004 Cytokines and steroidogenesis. Molecular and Cellular Endocrinology 215 135-141.
3. Bulletti C & de Ziegler D 2005 Uterine contractility and embryo implantation. Current Opinion in Obstetrics & Gynecology 17 265-276.
4. Cella M, Aisemberg J, Sordelli MS, Billi S, Farina M, Franchi AM & Ribeiro ML 2006 Prostaglandins modulate nitric oxide synthase activity early in time in the uterus of estrogenized rat challenged with lipopolysaccharicle. European Journal of Pharmacology 534 218-226.
5. Chaouat G, Menu E, Clark DA, Dy M, Minkowski M & Wegmann TG 1990 Control of fetal survival in CBA x DBA/2 mice by lymphokine therapy. Journal of Reproduction and Fertility 89 447-458.
6. Chatterjee S, Gangula PR, Dong YL & Yallampalli C 1996 Immunocytochemical localization of nitric oxide synthase-III in reproductive organs of female rats during the oestrous cycle. Histochemical Journal 28 715-723.
7. Chwalisz K & Garfield RE 2000 Role of nitric oxide in implantation and menstruation. Human Reproduction 3 96-111.
8. Chwalisz K, Buhimschi I & Garfield RE 1996 Role of nitric oxide in obstetrics. Prenatal and Neonatal Medicine 1 292-328.
9. Chwalisz K, Winterhager E, Thienel T & Garfield RE 1999 Synergistic role of nitric oxide and progesterone during the establishment of pregnancy in the rat. Human Reproduction 14 542-552.
10. Clark KE, Mills EG, Stys SJ & Seeds AE 1981 Effects of vasoactive polypeptides on the uterine vasculature. American Journal of Obstetrics and Gynecology 139 182-188.
11. Cutolo M 2000 Sex hormone adjuvant therapy in rheumatoid arthritis. Rheumatic Diseases Clinics of North America 26 881-895.
12. Delgado M, Abad C, Martinez C, Juarranz MG, Arranz A, Gomariz RP & Leceta J 2002 Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases. Journal of Molecular Medicine 80 16-24.
13. Durant S, Christeff N, Coulaud J, Nunez EA, Dardenne M & Homo-Delarche F 1998 Basal concentrations of various steroids in the nonobese diabetic (NOD) Mouse and effect of immobilization stress. Autoimmunity 28 249-258.
14. Ekström J, Mansson B & Tobin G 1983 Vasoactive intestinal peptide evokes secretion of fluid and protein from rat salivary glands and the development of supersensitivity. Acta Physiologica Scandinavica 119 169-175.
15. Elson J & Jurkovic D 2004 Biochemistry in diagnosis and management of abnormal early pregnancy. Current Opinion in Obstetrics & Gynecology 16 339-344.
16. Falcone M & Sarvetnick N 1999 Cytokines that regulate autoimmune responses. Current Opinion in Immunology 11 670-676.
17. Farina M, Ribeiro ML & Franchi A 2001 Nitric oxide synthases in pregnant rat uterus. Reproduction 121 403-407.
18. Farina M, Ribeiro ML, Weissmann C, Estevez A, Billi S, Vercelli C & Franchi A 2004 Biosynthesis and catabolism of prostaglandin F2alpha (PGF2alpha) are controlled by progesterone in the rat uterus during pregnancy. Journal of Steroid Biochemistry and Molecular Biology 91 211-218.
19. Gressens P, Paindaveine B, Hill JM, Evrard P & Brenneman DE 1998 Vasoactive intestinal peptide shortens both G1 and S phases of neural cell cycle in whole postimplantation cultured mouse embryos. European Journal of Neuroscience 10 1734-1742.
20. Hunt JS, Miller L, Vassmer D & Croy BA 1997 Expression of the inducible nitric oxide synthase gene in mouse uterine leukocytes and potential relationships with uterine function during pregnancy. Biology of Reproduction 57 827-836.
21. Inoue Y, Kaku K, Kaneko T, Yanahara N & Kanno T 1985 Vasoactive intestinal peptide binding to specific receptors on rat parotid acinar cells induces amylase secretion accompanied by cyclic adenosine 3′-5′-monophosphate. Endocrinology 116 686-692.
22. Jaffe BM & Behrman HR 1974 Methods of Hormone Radioimmunoassay, New York, USA: Academic Press.
23. Jovanovic A, Jovanovic S, Tulic I & Grbovic L 1998 Predominant role for nitric oxide in the relaxation induced by vasoactive intestinal polypeptide in human uterine artery. Molecular Human Reproduction 4 71-76.
24. Juarranz MG, Santiago B, Torroba M, Gutierrez-Cañas I, Palao G, Galindo M, Abad C, Martinez C, Leceta J, Pablos JL & Gomariz RP 2004 Vasoactive intestinal peptide modulates proinflammatory mediator synthesis in osteoarthritic and rheumatoid synovial cells. Rheumatology 43 416-422.
25. MacMicking J, Xie QW & Nathan C 1997 Nitric oxide and macrophage function. Annual Review of Immunology 15 323-350.
26. Miceli F, Tropea A, Minici F, Navarra P, Lanzone A & Apa R 2003 Interleukin-1 beta stimulates progesterone production by in vitro human luteal cells: evidence of a mediatory role of prostaglandins. Journal of Clinical Endocrinology and Metabolism 88 2690-2694.
27. Moncada S, Palmer RMJ & Higgs EA 1991 Nitric oxide physiology, pathophysiology and pharmacology. Pharmacological Reviews 43 109-142.
28. Murthy KS, Zhang KM, Jin JG, Grider JR & Makhlouf GM 1993 VIP-mediated G protein-coupled Ca + 2 influx activates a constitutive NOS in dispersed gastric muscle cells. American Journal of Physiology 265 G660-G671.
29. Nelson JL & Ostensen M 1997 Pregnancy and rheumatoid arthritis. Rheumatic Diseases Clinics of North America 23 195-212.
30. Ogando DG, Paz D, Cella M & Franchi AM 2003 The fundamental role of increased production of nitric oxide in lipopolysacaride-induced embryonic resorption in mice. Reproduction 125 95-110.
31. Olsen NJ & Kovacs WJ 2002 Hormones, pregnancy, and rheumatoid arthritis. Journal of Gender-Specific Medicine 5 28-37.
32. Ota H, Igarashi S, Oyama N, Suzuki Y & Tanaka T 1999 Optimal levels of nitric oxide are crucial for implantation in mice. Reproduction, Fertility, and Development 11 183-188.
33. Ottesen B, Ulrichsen H, Fahrenkrug J, Larsen JJ, Wagner G, Schierup L & Sondergaard F 1982 Vasoactive intestinal polypeptide and the female genital tract: relationship to reproductive phase and delivery. American Journal of Obstetrics and Gynecology 143 414-420.
34. Par G, Bartok B & Szekeres-Bartho J 2000 Cyclooxygenase is involved in the effects of progesterone-induced blocking factor on the production of interleukin 12. American Journal of Obstetrics and Gynecology 183 126-130.
35. Purcell TL, Given R, Chwalisz K & Garfield RE 1999 Nitric oxide synthase distribution during implantation in the mouse. Molecular Human Reproduction 5 467-475.
36. Raghupathy R 1997 Th1-type immunity is incompatible with successful pregnancy. Immunology Today 18 478-482.
37. Ribeiro ML, Cella M, Farina M & Franchi A 2003 Crosstalk between nitric oxide synthase and cyclooxygenase metabolites in the estrogenized rat uterus. Prostaglandins, Leukotrienes, and Essential Fatty Acids 4 285-290.
38. Robinson CP, Yamamoto H, Peck AB & Humphreys-Beher MG 1996 Genetically programmed development of salivary gland abnormalities in the NOD (non obese diabetic)-scid mouse in the absence of detectable lymphocytic infiltration: a potential trigger for sialoadenitis of NOD mice. Clinical Immunology and Immunopathology 79 50-59.
39. Rosignoli F & Perez Leiros C 2002 Nitric oxide synthase I and VIP-activated signaling are affected in salivary glands of NOD mice. Journal of Neuroimmunology 130 109-116.
40. Rosignoli F, Roca V, Meiss R, Pregi N & Pérez Leirós C 2004 Inhibition of calcium-calmodulin kinase restores nitric oxide production and signaling in submandibular glands of a mouse model of salivary dysfunction. British Journal of Pharmacology 143 1058-1065.
41. Rosignoli F, Roca V, Meiss R, Leceta J, Gomariz RP & Pérez Leirós C 2005 Defective signalling in salivary glands precedes the autoimmune response in the non-obese diabetic mouse model of sialadenitis. Clinical and Experimental Immunology 142 411-418.
42. Rovensky J, Radikova Z, Imrich R, Greguska O, Vigas M & Macho L 2004 Gonadal and adrenal steroid hormones in plasma and synovial fluid of patients with rheumatoid arthritis. Endocrine Regulations 38 143-149.
43. Rovensky J, Kvetnansky R, Radikova Z, Imrich R, Greguska O, Vigas M & Macho L 2005 Hormone concentrations in synovial fluid of patients with rheumatoid arthritis. Clinical and Experimental Rheumatology 23 292-296.
44. Silver RM, Edwin SS, Trautman MS, Simmons DL, Branch DW, Dudley DJ & Mitchell MD 1995 Bacterial lipopolysaccharide-mediated fetal death. Production of a newly recognized form of inducible cyclooxygenase (COX-2) in murine decidua in response to lipopolysaccharide. Journal of Clinical Investigation 95 725-731.
45. Spong CY, Lee SJ, McCune SK, Gibney G, Abebe DT, Alvero R, Brenneman DE & Hill JM 1999 Maternal regulation of embryonic growth: the role of vasoactive intestinal peptide. Endocrinology 140 917-924.
46. Szekeres-Bartho J 2002 Immunological relationship between the mother and the fetus. International Reviews of Immunology 21 471-495.
47. Szekeres-Bartho J & Wegmann TG 1996 A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance. Journal of Reproductive Immunology 31 81-95.
48. Taiym S, Haghighat N & Al-Hashimi I 2004 A comparison of the hormone levels in patients with Sjogren's syndrome and healthy controls. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 97 579-583.
49. Valentino R, Savastano S, Tommaselli AP, Riccio A, Mariniello P, Pronesti G, De Divitiis PM & Lombardi G 1993 Hormonal pattern in women affected by rheumatoid arthritis. Journal of Endocrinological Investigation 16 619-624.
50. van Blokland SC & Versnel MA 2002 Pathogenesis of Sjogren's syndrome: characteristics of different mouse models for autoimmune exocrinopathy. Clinical Immunology 103 111-124.
51. Wang H & Dey SK 2005 Lipid signaling in embryo implantation. Prostaglandins & Other Lipid Mediators 77 84-102.
52. Zhang X, Wang HM, Lin HY, Liu GY, Li QL & Zhu C 2004 Regulation of matrix metalloproteinases (MMPS) and their inhibitors (TIMPS) during mouse peri-implantation: role of nitric oxide. Placenta 25 243-252.